Abstract
The sequence-specific triplex formation against duplex DNA offers a potential basis for genome targeting technology, such as diagnostics, regulation of gene expression and sequencing technologies. In an antiparallel triplex DNA, a purine-rich triplex forming oligonucleotide (TFO) consisting of a dG, dA or T forms two reverse Hoogsteen hydrogen bonds with a GC, AT or AT base pair of the duplex DNA, respectively, with a high selectivity in a sequence specific manner. However, there is no natural nucleoside which can recognize the inverted CG and TA base pair of the duplex DNA. Therefore, the development of recognition molecules for the CG and TA inversion sites with a high stability and selectivity has been demanded for the triplex forming technology. In this chapter, we describe the design and synthesis of W-shaped nucleoside analogues (WNA-βT) and pseudo-dC derivatives (MeAP-ΨdC) for selective recognition of the TA and CG base pair, respectively, to expand the triplex-forming sequence.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Thuong NT, Helene C (1993) Sequence-specific recognition and modification of double-helical DNA by oligonucleotides. Angew Chem Int Ed 32:666–690
Chan PP, Glazer PM (1997) Triplex DNA: fundamentals, advances, and potential applications for gene therapy. J Mol Med 75:267–282
Buchini S, Leumann CJ (2003) Recent improvements in antigene technology. Curr Opin Chem Biol 7:717–726
Jain A, Wang G, Vasquez KM (2008) DNA triple helices: biological consequences and therapeutic potential. Biochimie 90:1117–1130
Moser HE, Dervan PB (1987) Sequence-specific cleavage of double helical DNA by triple helix formation. Sicence 238:645–650
Rajagopal P, Feigon L (1989) NMR studies of triple-strand formation from the homopurine-homopyrimidine deoxyribonucleotides d(GA)4 and d(TC)4. Biochemistry 28:7859–7870
Beal PA, Dervan PB (1991) Second structural motif for recognition of DNA by oligonucleotide-directed triple-helix formation. Science 251:1360–1363
Beal PA, Dervan PB (1992) The influence of single base triplet changes on the stability of a pur.pur.pyr triple helix determined by affinity cleaving. Nucleic Acids Res 20:2773–2776
Huang CY, Miller PS (1996) Triplex formation by oligonucleotides containing novel deoxycytidine derivatives. Nucleic Acids Res 24:2606–2613
Rusling DA, Powers VEC, Ranasinghe RT, Wang Y, Osborne SD, Brown T, Fox KR (2005) Four base recognition by triplex-forming oligonucleotides at physiological pH. Nucleic Acids Res 33:3025–3032
Semenyuk A, Darian E, Liu J, Majumdar A, Cuenoud B, Miller PS, MacKerell AD, Seidman MM (2010) Targeting of an interrupted polypurine:polypyrimidine sequence in mammalian cells by a triplex-forming oligonucleotide containing a novel base analogue. Biochemistry 49:7867–7878
Hari Y, Akabane M, Obika S (2013) 2′,4′-BNA bearing a chiral guanidinopyrrolidine containing nucleobase with potent ability to recognize the CG base pair in a parallel-motif DNA triplex. Chem Commun 49:7421–7423
Ohkubo A, Yamada K, Ito Y, Yoshimura K, Miyauchi K, Kanamori T, Masaki Y, Seio K, Yuasa H, Sekine M (2015) Synthesis and triplex-forming properties of oligonucleotides capable of recognizing corresponding DNA duplexes containing four base pairs. Nucleic Acids Res 43:5675–5686
Stilz HU, Dervan PB (1993) Specific recognition of CG base pairs by 2-deoxynebularine within the purine-purine-pyrimidine triple-helix motif. Biochemistry 32:2177–2185
Parel SP, Leumann CJ (2001) Triple-helix formation in the antiparallel binding motif of oligodeoxynucleotides containing N9- and N7-2-aminopurine deoxynucleosides. Nucleic Acids Res 29:2260–2267
Kolganova NA, Shchyolkina AK, Chudinov AV, Zasedatelev AS, Florentiev VL, Timofeev EN (2012) Targeting duplex DNA with chimeric α,β-triplex-forming oligonucleotides. Nucleic Acids Res 40:8175–8185
Sasaki S, Yamauchi H, Nagatsugi F, Takahashi R, Taniguchi Y, Maeda M (2001) W-shape nucleic acid (WNA) for selective formation of nonnatural anti-parallel triplex including a TA interrupting site. Tetrahedron Lett 42(39):6915–6918
Sasaki S, Taniguchi Y, Takahashi R, Senko Y, Kodama K, Nagatsugi F, Maeda M (2003) Selective formation of stable triplexes including a TA or a CG interrupting site with new bicyclic nucleoside analogues (WNA). J Am Chem Soc 126:516–528
Taniguchi Y, Nakamura A, Senko Y, Kodama K, Nagatsugi F, Sasaki S (2005) Expansion of triplex recognition codes by the use of novel bicyclic nucleoside derivatives (WNA). Nucleosides Nucleotides Nucleic Acids 24:823–827
Taniguchi Y, Nakamura A, Senko Y, Nagatsugi F, Sasaki S (2006) Effects of halogenated WNA derivatives on sequence dependency for expansion of recognition sequences in non-natural-type triplexes. J Org Chem 71:2115–2122
Nasr T, Taniguchi Y, Sasaki S (2007) Synthesis of 1′-phenyl substituted nucleoside analogs. Heterocycles 71:2659–2668
Taniguchi Y, Togo M, Aoki E, Uchida Y, Sasaki S (2008) Synthesis of p-amino-WNA derivatives to enhance the stability of the anti-parallel triplex. Tetrahedron 64:7164–7170
Taniguchi Y, Uchida Y, Takaki T, Aoki E, Sasaki S (2009) Recognition of the CG interrupting site by W-shaped nucleoside analogs (WNA) having the pyrozole ring in an anti-parallel triplex DNA. Bioorg Med Chem 17:6803–6810
Aoki E, Taniguchi Y, Wada Y, Sasaki S (2012) Efficient DNA strand displacement by a W-shaped nucleoside analogue (WNA-βT) containing an ortho-methyl-substituted phenyl ring. Chembiochem 13:1152–1160
Nasr T, Taniguchi Y, Takaki T, Okamura H, Sasaki S (2012) Properties of oligonucleotide with phenyl-substituted carbocyclic nucleoside analogues for the formation of duplex and triplex DNA. Nucleosides Nucleotides Nucleic Acids 31:8441–8460
Taniguchi Y, Okamura H, Fujino N, Sasaki S (2013) Synthesis of 1′-phenyl-2-OMe ribose analogues connecting the thymine base at the 1′ position through a flexible linker for the formation of a stable anti-parallele triplex DNA. Tetrahedron 69:600–606
Taniguchi Y, Tomizaki A, Matsueda N, Okamura H, Sasaki S (2015) Enhancement of TFO triplex formation by conjugation with pyrene via click chemistry. Chem Pharm Bull 63:920–926
Shen C, Buck A, Polat B, Schmid-Kotsas A, Matuschek C, Gross H-J, Bachem M, Reske SN (2003) Triplex-forming oligodeoxynucleotides targeting survivin inhibit proliferation and induce apoptosis of human lung carcinoma cells. Cancer Gene Ther 10:403–410
Zendegui JG, Vasquez KM, Tinsley JH, Kessler DJ, Hogan ME (1992) In vivo stability and kinetics of absorption and disposition of 3′ phosphopropyl amine oligonucleotides. Nucleic Acids Res 20:307–314
Gamper HB, Reed MW, Cox T, Virosco JS, Adams AD, Gall AA, Scholler JK, Meyer RB (1993) Facile preparation of nuclease resistant 3′ modified oligodeoxynucleotides. Nucleic Acids Res 21:145–150
Shin S, Sung B-J, Cho Y-S, Kim H-J, Ha N-C, Hwang J-I, Chung C-W, Jung Y-K, Oh B-H (2001) An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. Biochemistry 40:1117–1123
Taniguchi Y, Sasaki S (2012) An efficient antigene activity and antiproliferative effect by targeting the Bcl-2 or survivin gene with triplex forming oligonucleotides containing a W-shaped nucleoside analogue (WNA-βT). Org Biomol Chem 10:8336–8341
Dittrich K, Gu J, Tinder R, Hogan M, Gao X (1994) T·C·G triplet in an antiparallel purine·purine·pyrimidine DNA triplex conformational studies by NMR. Biochemistry 33:4111–4120
Durland RH, Rao TS, Revankar GR, Tinsley JH, Myrick MA, Seth DM, Rayford J, Singh P, Jayaraman K (1994) Binding of T and T analogs to CG base pairs in antiparallel triplexes. Nucleic Acids Res 22:3233–3240
Okamura H, Taniguchi Y, Sasaki S (2013) N-(Guanidinoethyl)-2′-deoxy-5-methylisocytidine exhibits selective recognition of a CG interrupting site for the formation of anti-parallel triplexes. Org Biomol Chem 11:3918–3924
Okamura H, Taniguchi Y, Sasaki S (2014) An isocytidine derivative with a 2-amino-6-methylpyridine unit for selective recognition of the CG interrupting site in an antiparallel triplex DNA. Chembiochem 15:2374–2378
Okamura H, Taniguchi Y, Sasaki S (2016) Aminopyridinyl-pseudodeoxycytidine derivatives selectively stabilize antiparallel triplex DNA with multiple CG inversion sites. Angew Chem Int Ed. 55:12445-12449
Kim H-J, Leal NA, Benner SA (2009) 2′-deoxy-1-methylpseudocytidine, a stable analog of 2′-deoxy-5-methylisocytidine. Bioorg Med Chem 17:3728–3232
Hildbrand S, Blaser A, Parel SP, Leumann CJ (1997) 5-substituted 2-aminopyridine C-nucleosides as protonated cytidine equivalents: increasing efficiency and selectivity in DNA triple-helix formation. J Am Chem Soc 119:5499–5511
Ito H, Kyo S, Kanaya T, Takakura M, Inoue M, Namiki M (1998) Expression of human telomerase subunits and correlation with telomerase activity in urothelial cancer. Clin Cancer Res 4:1603–1608
Takakura M, Kyo S, Kanaya T, Hirano H, Takeda J, Yutsudo M, Inoue M (1999) Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res 59:551–557
Govan JM, Uprety R, Hemphill J, Lively MO, Deiters A (2012) Regulation of transcription through light-activation and light-deactivation of triplex-forming oligonucleotides in mammalian cells. ACS Chem Biol 7:1247–1256
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Taniguchi, Y., Sasaki, S. (2018). Development of Triplex Forming Oligonucleotide Including Artificial Nucleoside Analogues for the Antigene Strategy. In: Obika, S., Sekine, M. (eds) Synthesis of Therapeutic Oligonucleotides. Springer, Singapore. https://doi.org/10.1007/978-981-13-1912-9_15
Download citation
DOI: https://doi.org/10.1007/978-981-13-1912-9_15
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-1911-2
Online ISBN: 978-981-13-1912-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)